
Post doctorat, Department of Physiology,University of Toronto, Canada
Division of Endocrinology, Gerontology and Metabolism, Medicine School, University of Stanford, Veteran Hospital, Californie, Etats-Unis
2011-2016 Laboratoire d’Ethique Médicale et Médecine légale (EA 6945), Faculté de médecine – Centre Universitaire des Saints-Pères, Université Paris Descartes, Paris 5
2003- 2011 Laboratoire de Biologie de la Nutrition (EA 2498), Faculté de Pharmacie, Université Paris 5
1987-2002 Unité Inserm U341, Génie Biomédical et Diabète Sucré, Service de Diabétologie, Hôpital Hôtel-Dieu, Paris
Launoy G, Duchange N, Darquy S, Moutel G. Participation to organized screening programs: Individual and collective stakes. Bull Cancer. 2018 May 28. pii: S0007-4551(18)30137-1. doi: 10.1016/j.bulcan.2018.04.008.
Moutel G, Duchange N, Lièvre A, Orgerie MB, Jullian O, Sancho-Garnier H, Darquy S. Low participation in organized colorectal cancer screening in France: underlying ethical issues. Eur J Cancer Prev. 2017 Nov 24.
Moutel G, Duchange N, Lièvre A, Darquy S. Addressing low participant in colorectal cancer screening: Respect for individual freedom versus the community good. Dig Liver Dis. 2017 Sep;49(9):1064-1065.
Mamzer MF, Duchange N, Darquy S, Marvanne P, Rambaud C, Marsico G, Cerisey C, Scotté F, Burgun A, Badoual C, Laurent-Puig P, Hervé C. Partnering with patients in translational oncology research: ethical approach. J Transl Med. 2017 Apr 23;15(1):80.
Moutel G, Duchange N, Darquy S, de Montgolfier S, Papin-Lefebvre F, Jullian O, Viguier J, Sancho-Garnier H; GRED French National Cancer Institute.Women’s participation in breast cancer screening in France–an ethical approach. BMC Med Ethics. 2014 Aug 16;15:64.